BlackRock's Biotechnology Portfolio

Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

Neurogene is a developer of genetic medicines intended to improve patient outcomes for neurological disorders.

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Inventiva Pharma is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.

Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.

OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.

Abcuro develops immunotherapies to treat autoimmunity and cancer.

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.

TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.

Verge Genomics uses machine learning and human genomics to accelerate drug discovery.

Solugen is a carbon negative moleucle factory that replaces petroleum-based products with plant-derived substitutes.

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.

Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.

Omega Therapeutics offers a proprietary epigenomic programming platform.

Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies.

Motif is a food technology company that offers plant-based and animal-free food options.

Benson Hill is a provider of crop design platform to develop healthier and more sustainable food and ingredients.

Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

Sigilon Therapeutics is a biotech company that specializes in creating immune-privileged products for treating acute and chronic diseases.

Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.